| Dr David Elkayam, MD | |
|
3015 Squalicum Pkwy, Suite #180, Bellingham, WA 98225-1945 | |
| (360) 733-5733 | |
| (360) 733-1859 |
| Full Name | Dr David Elkayam |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 42 Years |
| Location | 3015 Squalicum Pkwy, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871589234 | NPI | - | NPPES |
| 1112291 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 25387 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bellingham, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellingham Asthma Allergy Immunology Clinic Ps | 6103810304 | 3 |
News Archive
People with bone, joint and muscle pain saw their symptoms worsen during lockdown - according to new research from the University of East Anglia.
Massachusetts General Hospital (MGH) investigators may have found a way to solve a problem that has plagued a group of drugs called ligand-mimicking integrin inhibitors, which have the potential to treat conditions ranging from heart attacks to cancer metastasis.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Mati Muñoz is 65 years old - filled with the enthusiastic energy that comes with a second chance at life. A decade ago, says Muñoz, who lives in Woodbridge Township, N.J., her liver was being destroyed by hepatitis C, a viral disease she believes she contracted as a girl in her native Cuba from a poorly sterilized needle used in a medical procedure.
› Verified 6 days ago
| Entity Name | Bellingham Asthma Allergy Immunology Clinic Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174672281 PECOS PAC ID: 6103810304 Enrollment ID: O20040412000658 |
News Archive
People with bone, joint and muscle pain saw their symptoms worsen during lockdown - according to new research from the University of East Anglia.
Massachusetts General Hospital (MGH) investigators may have found a way to solve a problem that has plagued a group of drugs called ligand-mimicking integrin inhibitors, which have the potential to treat conditions ranging from heart attacks to cancer metastasis.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Mati Muñoz is 65 years old - filled with the enthusiastic energy that comes with a second chance at life. A decade ago, says Muñoz, who lives in Woodbridge Township, N.J., her liver was being destroyed by hepatitis C, a viral disease she believes she contracted as a girl in her native Cuba from a poorly sterilized needle used in a medical procedure.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Elkayam, MD 3015 Squalicum Pkwy, Suite #180, Bellingham, WA 98225-1945 Ph: (360) 733-5733 | Dr David Elkayam, MD 3015 Squalicum Pkwy, Suite #180, Bellingham, WA 98225-1945 Ph: (360) 733-5733 |
News Archive
People with bone, joint and muscle pain saw their symptoms worsen during lockdown - according to new research from the University of East Anglia.
Massachusetts General Hospital (MGH) investigators may have found a way to solve a problem that has plagued a group of drugs called ligand-mimicking integrin inhibitors, which have the potential to treat conditions ranging from heart attacks to cancer metastasis.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Mati Muñoz is 65 years old - filled with the enthusiastic energy that comes with a second chance at life. A decade ago, says Muñoz, who lives in Woodbridge Township, N.J., her liver was being destroyed by hepatitis C, a viral disease she believes she contracted as a girl in her native Cuba from a poorly sterilized needle used in a medical procedure.
› Verified 6 days ago
Dr. William Howard Anderson, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3130 Ellis St, Bellingham, WA 98225 Phone: 425-339-5412 Fax: 360-363-4750 | |
Maryanne B. Scott, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4545 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-752-5690 |